News | January 14, 2008

Second Annual Symposium Examines “Advances in Thoracic Oncology”

January 15, 2008 – On March 7 and 8, Yale School of Medicine and Nevada Cancer Institute (NVCI) will hold the Second Annual John R. Murren Memorial Symposium: “Advances in Thoracic Oncology” at The Red Rock Conference Center in Las Vegas.

The Yale School of Medicine designates this educational activity for a maximum of 8.5 AMA PRA Category 1 Credits.

John Murren M.D. was among the founders of both The Yale Cancer Center Thoracic Oncology Program and Nevada Cancer Institute. In honor of his efforts, the Course Directors, Drs. Lynn Tanoue, Nicholas Vogelzang, Giuseppe Pizzorno, and Daniel M. Goodenberger have gathered 10 “of the most formidable minds in cancer research in the area of thoracic oncology” to provide evidence-based education to multidisciplinary clinicians involved in the screening, diagnosis and treatment of patients with lung cancer and abnormal scans of the chest.

Participants who attend will be able to:
- Report on the current state of lung cancer care
- Review innovations in minimally invasive thoracic surgery and bronchoscopy
- Apply new advances in imaging for small pulmonary nodules
- Identify novel approaches to radiotherapy for lung cancer
- Assess updates in mesothelioma
- Engage in pathologic evaluation of bronchoalveolar carcinoma
- Discuss molecular pharmacology in lung cancer
- Understand and apply novel and targeted therapies for lung cancer
- Integrate evidence-based guidelines for lung cancer staging and
- Analyze current strategies of prevention and therapy

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...